110 related articles for article (PubMed ID: 29803740)
1. Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation.
Basu S; Chaudhary N; Shah S; Braggs C; Sawant A; Vaz S; Thorat R; Gupta S; Dalal SN
Exp Cell Res; 2018 Aug; 369(2):251-265. PubMed ID: 29803740
[TBL] [Abstract][Full Text] [Related]
2. Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APC
Raghavan R; Koyande N; Beher R; Chetlangia N; Ramadwar M; Pawade S; Thorat R; van Hengel J; Sklyarova T; van Roy F; Dalal SN
Biochem Biophys Res Commun; 2022 Jan; 586():14-19. PubMed ID: 34823217
[TBL] [Abstract][Full Text] [Related]
3. Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis.
Khapare N; Kundu ST; Sehgal L; Sawant M; Priya R; Gosavi P; Gupta N; Alam H; Karkhanis M; Naik N; Vaidya MM; Dalal SN
PLoS One; 2012; 7(6):e38561. PubMed ID: 22701666
[TBL] [Abstract][Full Text] [Related]
4. MMP7 is required to mediate cell invasion and tumor formation upon Plakophilin3 loss.
Basu S; Thorat R; Dalal SN
PLoS One; 2015; 10(4):e0123979. PubMed ID: 25875355
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin and plakoglobin recruit plakophilin3 to the cell border to initiate desmosome assembly.
Gosavi P; Kundu ST; Khapare N; Sehgal L; Karkhanis MS; Dalal SN
Cell Mol Life Sci; 2011 Apr; 68(8):1439-54. PubMed ID: 20859650
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
Kim SL; Min IS; Park YR; Lee ST; Kim SW
Int J Oncol; 2018 Dec; 53(6):2789-2799. PubMed ID: 30221676
[TBL] [Abstract][Full Text] [Related]
8. Plakophilin3 loss leads to an increase in autophagy and radio-resistance.
Chaudhary N; Joshi N; Doloi R; Shivashankar A; Thorat R; Dalal SN
Biochem Biophys Res Commun; 2022 Sep; 620():1-7. PubMed ID: 35772211
[TBL] [Abstract][Full Text] [Related]
9. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
[TBL] [Abstract][Full Text] [Related]
10. FERMT1 promotes cell migration and invasion in non-small cell lung cancer via regulating PKP3-mediated activation of p38 MAPK signaling.
Liu B; Feng Y; Xie N; Yang Y; Yang D
BMC Cancer; 2024 Jan; 24(1):58. PubMed ID: 38200443
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin2 promotes cell proliferation and migration in ovarian cancer through activation of the ERK/GSK3β/β-catenin signaling pathway.
Hao P; Li H; Wu A; Zhang J; Wang C; Xian X; Ren Q; Hao N; Wang Y; Yue F; Cui H
Life Sci; 2020 Dec; 262():118492. PubMed ID: 32980390
[TBL] [Abstract][Full Text] [Related]
12. Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis.
Kundu ST; Gosavi P; Khapare N; Patel R; Hosing AS; Maru GB; Ingle A; Decaprio JA; Dalal SN
Int J Cancer; 2008 Nov; 123(10):2303-14. PubMed ID: 18729189
[TBL] [Abstract][Full Text] [Related]
13. Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes.
Dubash AD; Kam CY; Aguado BA; Patel DM; Delmar M; Shea LD; Green KJ
J Cell Biol; 2016 Feb; 212(4):425-38. PubMed ID: 26858265
[TBL] [Abstract][Full Text] [Related]
14. PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer.
Lim V; Zhu H; Diao S; Hu L; Hu J
Biochem Biophys Res Commun; 2019 Jan; 508(2):646-653. PubMed ID: 30527804
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
Lin CW; Yang WE; Lee WJ; Hua KT; Hsieh FK; Hsiao M; Chen CC; Chow JM; Chen MK; Yang SF; Chien MH
Carcinogenesis; 2016 Jul; 37(7):712-722. PubMed ID: 27207653
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
Lee EK; Kim HJ; Lee KJ; Lee HJ; Lee JS; Kim DG; Hong SW; Yoon Y; Kim JS
Int J Oncol; 2011 Feb; 38(2):325-33. PubMed ID: 21132267
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
